Top Markets
Coin of the day
Brain+ A/S Brain+ A/S

Brain+ A/S

BRAINP
Rank in Stocks #39974
Brain+ A/S specializes in developing digital therapeutic solutions for... Brain+ A/S specializes in developing digital therapeutic solutions for individuals coping with Alzheimer's and various types of dementia. The company's portfolio includes Cognitive Stimulation Therapy (CST), which targets the primary symptoms of dementia, and Computerized Cognitive Training, a method designed for patients experiencing mild cognitive impairment. Additionally, Brain+ offers "Starry Night," a memory assessment tool crucial for the early detection and continuous monitoring of Alzheimer's disease. The firm also provides an intuitive interface that enables clinicians to effectively track and oversee patient treatment progress. Established in 2012, this Copenhagen, Denmark-based company was formerly a subsidiary of Brain+ Holding ApS.
Share Price
$0.00066685
Last synced: 2026-04-01
Market Cap
$285.01K
Change (1 day)
0.00%
Change (1 year)
-70.74%
Country
DK
Trade Brain+ A/S (BRAINP)

Category

P/B ratio for Brain+ A/S (BRAINP)
P/B ratio as of 2026 TTM: 0
According to Brain+ A/S latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Brain+ A/S from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors